Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance

被引:3
|
作者
Ostrowska-Lesko, Marta [1 ]
Rajtak, Alicja [2 ]
Moreno-Bueno, Gema [3 ,4 ,5 ]
Bobinski, Marcin [2 ]
机构
[1] Med Univ Lublin, Chair & Dept Toxicol, 8B Jaczewskiego St, PL-20090 Lublin, Poland
[2] Med Univ Lublin, Chair & Dept Oncol Gynecol & Gynecol 1, Lublin, Poland
[3] Univ Autonoma Madrid UAM, Biochem Dept, Inst Invest Biomed Sols Morreale IIBm CISC, Madrid, Spain
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
[5] Fdn MD Anderson Int FMDA, Madrid, Spain
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2024年 / 1879卷 / 01期
关键词
Non-cellular components; Ovarian cancer; Tumor microenvironment; TME; Chemotherapy resistance; CARBONIC-ANHYDRASE-IX; EXTRACELLULAR-MATRIX; TENASCIN-C; CISPLATIN RESISTANCE; PACLITAXEL RESISTANCE; PLATINUM-RESISTANT; PRIMARY SURGERY; LYSYL OXIDASE; OPEN-LABEL; NEOADJUVANT CHEMOTHERAPY;
D O I
10.1016/j.bbcan.2023.189036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor microenvironment (TME) components play a crucial role in cancer cells' resistance to chemotherapeutic agents. This phenomenon is exceptionally fundamental in patients with ovarian cancer (OvCa), whose outcome depends mainly on their response to chemotherapy. Until now, most reports have focused on the role of cellular components of the TME, while less attention has been paid to the stroma and other non-cellular elements of the TME, which may play an essential role in the therapy resistance. Inhibiting these components could help define new therapeutic targets and potentially restore chemosensitivity. The aim of the present article is both to summarize the knowledge about non-cellular components of the TME in the development of OvCa chemoresistance and to suggest targeting of non-cellular elements of the TME as a valuable strategy to overcome chemoresistance and to develop new therapeutic strategies in OvCA patients.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
    Malgorzata Banys-Paluchowski
    Tanja Fehm
    Hans Neubauer
    Peter Paluchowski
    Natalia Krawczyk
    Franziska Meier-Stiegen
    Charlotte Wallach
    Anna Kaczerowsky
    Gerhard Gebauer
    Archives of Gynecology and Obstetrics, 2020, 301 : 1027 - 1035
  • [22] Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
    Xiong, Zhuo
    Ha, Chunfang
    Li, Ruyue
    Wu, Mingyong
    Wei, Meng
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024, 89 (06) : 469 - 477
  • [23] Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
    Banys-Paluchowski, Malgorzata
    Fehm, Tanja
    Neubauer, Hans
    Paluchowski, Peter
    Krawczyk, Natalia
    Meier-Stiegen, Franziska
    Wallach, Charlotte
    Kaczerowsky, Anna
    Gebauer, Gerhard
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (04) : 1027 - 1035
  • [24] Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
    Cerro, Paulina A.
    Mascaraque, Marta
    Gallego-Rentero, Maria
    Almenara-Blasco, Manuel
    Nicolas-Morala, Jimena
    Luis Santiago, Juan
    Gonzalez, Salvador
    Gracia-Cazana, Tamara
    Juarranz, Angeles
    Gilaberte, Yolanda
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy
    Zhang, Jingtao
    Liu, Shuai
    Chen, Xiubao
    Xu, Xiangdong
    Xu, Fei
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [26] Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma
    Liu, Xue
    Xu, Chenyang
    Guo, Tianwei
    Zhan, Shenghua
    Quan, Qiuying
    Li, Mengsi
    Wang, Ziyi
    Zhang, Xueguang
    Guo, Lingchuan
    Cao, Lei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer
    Malla, Ramarao
    Bhamidipati, Priyamvada
    Samudrala, Anuveda Sree
    Nuthalapati, Yerusha
    Padmaraju, Vasudevaraju
    Malhotra, Aditya
    Rolig, Annah S.
    Malhotra, Sanjay V.
    CANCERS, 2025, 17 (07)
  • [28] Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy
    Oplawski, Marcin
    Srednicka, Agata
    Niewiadomska, Ewa
    Boron, Dariusz
    Januszyk, Piotr
    Grabarek, Beniamin Oskar
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Clinical significance of the tumor microenvironment in non-small cell lung cancer
    Shimizu, Katsuhiko
    Okita, Riki
    Nakata, Masao
    ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
  • [30] Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment
    Ahluwalia, Pankaj
    Ahluwalia, Meenakshi
    Mondal, Ashis K.
    Sahajpal, Nikhil S.
    Kota, Vamsi
    Rojiani, Mumtaz, V
    Kolhe, Ravindra
    CANCERS, 2021, 13 (16)